Musculoskeletal conditions of the upper and lower extremities are commonly treated with corticosteroid injections. Ketorolac, a parenteral nonsteroidal anti-inflammatory drug, represents an alternative injectant for common shoulder, hip, and knee conditions. A review of the current literature was conducted on the efficacy of ketorolac injection in musculoskeletal diseases. Several studies support the use and efficacy of ketorolac injection in subacromial bursitis, adhesive capsulitis, and hip and knee osteoarthritis. Given the systemic effects of glucocorticoid injections, ketorolac may be a safe and effective alternative in patients with musculoskeletal disease. However, more evidence is required to better understand the effects ketorolac has on the human body during inflammatory processes.
CITATION STYLE
Kiel, J., Applewhite, A. I., Bertasi, T. G. O., Bertasi, R. A. O., Seemann, L. L., Costa, L. M. C., … Pujalte, G. G. A. (2024, March 1). Ketorolac Injections for Musculoskeletal Conditions: A Narrative Review. Clinical Medicine and Research. Marshfield Clinic. https://doi.org/10.3121/cmr.2024.1847
Mendeley helps you to discover research relevant for your work.